{"url":"https://etfiq.com/holdings/stok/","section":"holdings","title":"STOK ETFs: 61 Funds That Hold Stoke Therapeutics Inc | ETFIQ","description":"61 thematic and core ETFs hold Stoke Therapeutics Inc (STOK). HLTH holds the most, at 3.35% of the fund on Nov 3, 2026.","as_of":"Nov 5, 2026","structured_data":[{"@type":"Dataset","@id":"https://etfiq.com/holdings/stok#data","name":"ETFs holding Stoke Therapeutics Inc","description":"Every US listed ETF that holds Stoke Therapeutics Inc, with each fund\u2019s published weight and filing date.","creator":{"@id":"https://etfiq.com/#org"},"isAccessibleForFree":true,"variableMeasured":["Share of fund","Holdings filing date"],"license":"https://etfiq.com/license/","publisher":{"@id":"https://etfiq.com/#org"},"inLanguage":"en","creativeWorkStatus":"Published","distribution":[{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/alternatives.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/core.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/crypto.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/funds.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/income.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/leverage.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/thematic.json"}]},{"@type":"FAQPage","mainEntity":[{"@type":"Question","name":"Which ETFs hold Stoke Therapeutics Inc?","acceptedAnswer":{"@type":"Answer","text":"61 thematic and core ETFs hold Stoke Therapeutics Inc, by holdings dated Jun 30, 2026 to Nov 3, 2026. The largest positions are HLTH at 3.35% of the fund on Nov 3, 2026, WDNA at 2.09% of the fund on Jun 30, 2026 and HELX at 1.33% of the fund on Jun 30, 2026. 1 income and other fund on it is listed apart."}}]},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"ETFIQ","item":"https://etfiq.com/"},{"@type":"ListItem","position":2,"name":"Holdings","item":"https://etfiq.com/holdings/"},{"@type":"ListItem","position":3,"name":"STOKE THERAPEUTICS INC","item":"https://etfiq.com/holdings/stok/"}]},{"@type":"WebPage","name":"STOK ETFs: 61 Funds That Hold Stoke Therapeutics Inc","description":"61 thematic and core ETFs hold Stoke Therapeutics Inc (STOK). HLTH holds the most, at 3.35% of the fund on Nov 3, 2026.","url":"https://etfiq.com/holdings/stok/","dateModified":"2026-11-04","isPartOf":{"@type":"WebSite","name":"ETFIQ","url":"https://etfiq.com"},"speakable":{"@type":"SpeakableSpecification","cssSelector":[".lede",".faq"]},"publisher":{"@id":"https://etfiq.com/#org"}}],"characters":6274,"truncated":false,"content":"ETFIQ / Holdings / STOKE THERAPEUTICS INC \n \n ETFs that hold Stoke Therapeutics Inc\n 61 thematic and core ETFs hold Stoke Therapeutics Inc , by holdings dated Jun 30, 2026 to Nov 3, 2026 . HLTH holds the most, at 3.35% of the fund on Nov 3, 2026 . The next largest are WDNA (2.09%) and HELX (1.33%). \n 1 income and other fund on it is listed below.\n Thematic and core funds that hold it\n Fund Name Share of the fund Holdings filed Asset \n HLTH Tema Healthcare AI ETF 3.35% Nov 3, 2026 Equity \n WDNA WisdomTree BioRevolution Fund 2.09% Jun 30, 2026 Equity \n HELX Franklin Genomic Advancements ETF 1.33% Jun 30, 2026 Equity \n GNOM Global X Genomics & Biotechnology ETF 1.13% Aug 31, 2026 Equity \n SGRW Harbor Active Small Cap Growth ETF 1.10% Jul 31, 2026 Equity \n SBIO ALPS Medical Breakthroughs ETF 1.00% Aug 31, 2026 Equity \n FMED Fidelity Disruptive Medicine ETF 0.95% Aug 31, 2026 Equity \n HRTS Tema Heart & Health ETF 0.73% Nov 3, 2026 Equity \n BBC Virtus Biotech Clinical Trials ETF 0.65% Jul 31, 2026 Equity \n XBI State Street SPDR S&P Biotech ETF 0.35% Nov 3, 2026 Equity \n TMED T. Rowe Price Health Care ETF 0.31% Jun 30, 2026 Equity \n FFSM Fidelity Fundamental Small-Mid Cap ETF 0.17% Jul 31, 2026 Equity \n SEIS SEI Select Small Cap ETF 0.17% Jun 30, 2026 Equity \n FSEG Fidelity Enhanced Small Cap Growth ETF 0.16% Jun 30, 2026 Equity \n IBBQ Invesco Nasdaq Biotechnology ETF 0.11% Nov 3, 2026 Equity \n IBB iShares Biotechnology ETF 0.10% Nov 3, 2026 Equity \n IWO iShares Russell 2000 Growth ETF 0.10% Nov 3, 2026 Equity \n ESSC Eventide Small Cap ETF 0.10% Jul 31, 2026 Equity \n TPSC Timothy Plan US Small Cap Core ETF 0.10% Jun 30, 2026 Equity \n VTWG Vanguard Russell 2000 Growth ETF 0.09% Sep 30, 2026 Equity \n PSC Principal U.S. Small-Cap ETF 0.09% Jun 30, 2026 Equity \n PWS Pacer WealthShield ETF 0.09% Jul 31, 2026 Equity \n FSML FRANKLIN SMALL CAP ENHANCED ETF 0.09% Jun 30, 2026 Equity \n FSMD Fidelity Small-Mid Multifactor ETF 0.09% Jul 31, 2026 Equity \n GSSC GS ActiveBeta U.S. Small Cap Equity ETF 0.07% Aug 31, 2026 Equity \n KBFR Innovator U.S. Small Cap Managed 10 Buffer ETF 0.07% Jul 31, 2026 Equity \n OMFS Invesco Russell 2000 Dynamic Multifactor ETF 0.06% Nov 3, 2026 Equity \n TMSL T. Rowe Price Small-Mid Cap ETF 0.06% Jun 30, 2026 Equity \n BBSC JPMorgan BetaBuilders U.S. Small Cap Equity ETF 0.06% Nov 3, 2026 Equity \n RFLR Innovator U.S. Small Cap Managed Floor ETF 0.06% Jul 31, 2026 Equity \n EES WisdomTree U.S. SmallCap Fund 0.06% Jun 30, 2026 Equity \n RESM Columbia Research Enhanced Small Cap ETF 0.05% Jun 30, 2026 Equity \n RSSL Global X Russell 2000 ETF 0.05% Jul 31, 2026 Equity \n ISCG iShares Morningstar Small-Cap Growth ETF 0.05% Nov 3, 2026 Equity \n IWM iShares Russell 2000 ETF 0.05% Nov 3, 2026 Equity \n VTWO Vanguard Russell 2000 ETF 0.05% Sep 30, 2026 Equity \n TNXT T. Rowe Price Innovation Leaders ETF 0.05% Jun 30, 2026 Equity \n SQLT iShares MSCI USA Small-Cap Quality Factor ETF 0.04% Nov 3, 2026 Equity \n SCHA Schwab U.S. Small-Cap ETF 0.04% Aug 31, 2026 Equity \n VFMO Vanguard U.S. Momentum Factor ETF 0.03% Sep 30, 2026 Equity \n ISCB 0.02% Jul 31, 2026 Equity \n PRFZ Invesco RAFI US 1500 Small-Mid ETF 0.02% Nov 3, 2026 Equity \n DFAS U.S. Small Cap Portfolio: ETF Class Shares 0.02% Jul 31, 2026 Equity \n VXF Vanguard Extended Market ETF 0.02% Sep 30, 2026 Equity \n MSML iShares MSCI USA Small-Cap ETF 0.02% Nov 3, 2026 Equity \n FHLC Fidelity MSCI Health Care Index ETF 0.01% Jul 31, 2026 Equity \n VHT Vanguard Health Care ETF 0.01% Sep 30, 2026 Equity \n MSSM Morgan Stanley Pathway Small-Mid Cap Equity ETF 0.01% Aug 31, 2026 Equity \n WSML iShares MSCI World Small-Cap ETF 0.01% Nov 3, 2026 Equity \n SMLF iShares U.S. Small-Cap Equity Factor ETF 0.01% Nov 3, 2026 Equity \n ONEQ Fidelity Nasdaq Composite Index ETF 0.01% Aug 31, 2026 Equity \n SPGM State Street SPDR Portfolio MSCI Global Stock Market ETF 0.01% Nov 3, 2026 Equity \n DFAU Dimensional US Core Equity Market ETF Jul 31, 2026 Equity \n DFSU Dimensional US Sustainability Core 1 ETF Jul 31, 2026 Equity \n SCHB Schwab U.S. Broad Market ETF Aug 31, 2026 Equity \n DFAC U.S. Core Equity 2 Portfolio ETF Class Shares Jul 31, 2026 Equity \n TILT Northern Trust Morningstar US Market Factor Tilt ETF Jul 31, 2026 Equity \n VTHR Vanguard Russell 3000 ETF Sep 30, 2026 Equity \n VTI Vanguard Morningstar Total Stock Market ETF Sep 30, 2026 Equity \n DFUS Dimensional U.S. Equity Market ETF Jul 31, 2026 Equity \n DCOR US Core Equity 1 Portfolio ETF Class Shares Jul 31, 2026 Equity \n Income and other funds that hold it\n Fund Name Share of the fund Holdings filed Category \n ITWO ProShares Russell 2000 High Income ETF 0.05% Aug 31, 2026 Income \n What this counts\n Stoke Therapeutics Inc (ticker STOK, listed in US) is matched in every holdings book ETFIQ publishes, by its ticker and name. A share of the fund is the weight its issuer published, as of the Holdings filed date. Shares, preferred shares and debt are told by each fund\u2019s N-PORT asset type. A fund holding only the company\u2019s debt or preferred shares is listed under them, not counted as holding its shares. Options, swaps, futures and cash do not count as holding a company: a call option on a share is not the share. Funds whose book is gross exposure, not a portfolio, are left out.\n Each row shows the date the fund last filed.\n Look up another company .\n Questions people ask\n Which ETFs hold Stoke Therapeutics Inc? 61 thematic and core ETFs hold Stoke Therapeutics Inc, by holdings dated Jun 30, 2026 to Nov 3, 2026. The largest positions are HLTH at 3.35% of the fund on Nov 3, 2026, WDNA at 2.09% of the fund on Jun 30, 2026 and HELX at 1.33% of the fund on Jun 30, 2026. 1 income and other fund on it is listed apart. \n Cite this page. ETFIQ, ETFs holding STOKE THERAPEUTICS INC, data as of Nov 5, 2026. https://etfiq.com/holdings/stok/ Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data .\n Other forms Plain ETFIQ, ETFs holding STOKE THERAPEUTICS INC, data as of Nov 5, 2026. https://etfiq.com/holdings/stok/ APA ETFIQ. (Nov 5, 2026). ETFs holding STOKE THERAPEUTICS INC. Retrieved from https://etfiq.com/holdings/stok/ Markdown [ETFs holding STOKE THERAPEUTICS INC (ETFIQ, Nov 5, 2026)](https://etfiq.com/holdings/stok/)","source":"ETFIQ, independent ETF data. Recomputed nightly from public filings and prices.","publisher":{"@id":"https://etfiq.com/#org","name":"ETFIQ","url":"https://etfiq.com"},"license":"https://etfiq.com/license/","license_text":"Data ETFIQ computes is free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.","citation":"ETFIQ, ETFs holding STOKE THERAPEUTICS INC, data as of Nov 5, 2026. https://etfiq.com/holdings/stok/"}